Author:
Farkouh Michael E.,Boden William E.,Bittner Vera,Muratov Victoria,Hartigan Pamela,Ogdie May,Bertolet Marnie,Mathewkutty Shiny,Teo Koon,Maron David J.,Sethi Sanjum S.,Domanski Michael,Frye Robert L.,Fuster Valentin
Funder
Merck
Pfizer
Bristol-Myers Squibb
Fujisawa
Kos Pharmaceuticals
Datascope
AstraZeneca
Key Pharmaceutical
Sanofi-Aventis
First Horizon
GE Healthcare
National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases
GlaxoSmithKline
Lantheus Medical Imaging, Inc.
Astellas Pharma US, Inc.
Merck & Co., Inc.
Abbott Laboratories, Inc.
Pfizer, Inc.
Abbott Laboratories Ltd.
MediSense Products
Bayer Diagnostics
Becton Dickinson and Company
J.R. Carlson Labs
Centocor, Inc.
Eli Lilly and Company
LipoScience, Inc.
Novartis Pharmaceuticals Corporation
Novo Nordisk, Inc
National Heart, Lung, and Blood Institute
Eli Lilly
Subject
Cardiology and Cardiovascular Medicine
Reference32 articles.
1. Heart disease and stroke statistics—2012 update: a report from the American Heart Association;Roger;Circulation,2012
2. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000;Ford;N Engl J Med,2007
3. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);JAMA,2001
4. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report;Chobanian;JAMA,2003
5. Standards of medical care in diabetes—2012;Diabetes Care,2012